Cytovance Biologics

Cytovance Biologics is a US-based contract development and manufacturing organisation (CDMO) specialising in the production of biologics for clinical and commercial use.

Company Description:
Founded with a mission to support the biopharmaceutical industry, Cytovance Biologics provides comprehensive services in the development and manufacturing of therapeutic proteins, antibodies, and plasmid DNA. Based in Oklahoma City, Cytovance serves biotech and pharmaceutical companies globally, offering end-to-end solutions from cell line development through to cGMP manufacturing. The company’s expertise lies in microbial fermentation, mammalian cell culture, and the production of microbial and mammalian-expressed biologics.

With state-of-the-art facilities and a commitment to quality, Cytovance leverages advanced technologies to deliver scalable, flexible, and cost-effective solutions. The company prioritises collaboration with its clients, ensuring tailored support for each stage of the biologics development lifecycle.

Key Products and Services:

• Cell Line Development: Custom development of microbial and mammalian cell lines.
• Process Development: Expertise in upstream and downstream development for biologics.
• cGMP Manufacturing: Clinical and commercial production using microbial fermentation and mammalian cell culture.
• Plasmid DNA Production: High-quality plasmid DNA manufacturing for gene therapy and vaccine applications.
• Regulatory Support: Comprehensive assistance with regulatory filings and compliance.

Final Paragraph:
With nearly two decades of industry experience, Cytovance Biologics has established itself as a trusted partner for biopharmaceutical companies worldwide. By combining technical expertise, a client-focused approach, and a dedication to quality, Cytovance continues to drive innovation and efficiency in the biologics manufacturing sector, helping to advance life-changing therapies to patients in need.